KayoThera, Inc. — Form D/A
KayoThera, Inc. of Seattle, WA, a company, filed a Form D amendment with the SEC on 2023-03-31. The offering totals $8.0M, of which $8.0M was reported sold. Industry: Other.
Offering
- Filed: 2023-03-31
- Form: D/A
- Accession: 0001778725-23-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $8.0M
- Amount sold: $8.0M
- Investors: 5
- Date of first sale: 2022-03-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-438820
Issuer
- Name: KayoThera, Inc.
- CIK: 0001778725
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 2815 Eastlake Avenue East, Suite 300, Seattle, WA, 98102
- Phone: (908) 731-6610
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| THONG LE | Director | Seattle, WA |
| THONG LE | Executive Officer | Seattle, WA |
| Suzanne Rettenmier | Executive Officer | Seattle, WA |
| Ian Howes | Executive Officer | Seattle, WA |
| Kendall Mohler | Director | Seattle, WA |
| Kendall Mohler | Executive Officer | Seattle, WA |
| Mark Esposito | Director | NY, NY |
| Mark Esposito | Executive Officer | NY, NY |
| KEN MOHLER | Director | PRINCETON, NJ |
| KEN MOHLER | Executive Officer | PRINCETON, NJ |
| Yibin Kang | Director | Princeton, NJ |
| George F Heinrich | Director | Princeton, NJ |
| James M Golubieski | Director | Princeton, NJ |
Other filings by this issuer (3)
More